Wenxue Zhao

机构：Luye Pharma (China) · ORCID：0000-0001-5380-1176

发表论文 99 篇 · 总被引 3133 次 · h-index 31

代表论文

Increased matrix stiffness promotes fibrogenesis of hepatic stellate cells through AP-1-induced chromatin priming (2025 · Communications Biology · 被引 12)
Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration (2025 · Cells · 被引 10)
Cumulative effects of weakly repressive regulatory regions in the 3’ UTR maintain PD-1 expression homeostasis in mammals (2023 · Communications Biology · 被引 9)
Precise Interference of RNA–Protein Interaction by CRISPR-Cas13-Mediated Peptide Competition (2023 · ACS Synthetic Biology · 被引 6)
In situ preparation of MoS2/Sv-ZnIn2S4/ZnS composites with directional charge transfer pathway and boosted photocatalytic hydrogen evolution activity (2025 · International Journal of Hydrogen Energy · 被引 5)
Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome (2023 · Heliyon · 被引 5)